Evaluation of Biopsy-Based Molecular Risk Prediction in Crescentic Glomerulonephritis
These results suggest that biopsy-based gene expression may provide the opportunity for improved risk stratification in crescentic GN; however, the genes evaluated in this study appear to have limited added clinical utility over existing risk scores.
Authors
- Peter Dromparis
- Arushi Gahlot Saini (ORCID: https://orcid.org/0000-0002-5747-8975)
- Benjamin Adam (ORCID: https://orcid.org/0000-0003-1908-1739)
- Michael Mengel (ORCID: https://orcid.org/0000-0002-7222-3356)
- Kristalee Watson
- Maziar Riazy (ORCID: https://orcid.org/0000-0002-2190-0687)
- Srinivas V. Koduru (ORCID: https://orcid.org/0000-0001-6827-2908)
- Sean J. Barbour
- Wirongrong Churngchow
- Ainslie Eberhart
Institutions
- University of British Columbia (CA)
- University of Alberta (CA)
Publication Details
- Journal
- Glomerular Diseases
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1159/000549541
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00